Search for: "United States v. AT&T, Inc." Results 6841 - 6860 of 8,841
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Apr 2010, 7:05 pm by Gideon
LaFave, Search and Seizure [3d Ed. 1996] § 3.5 [b], p. 259 n.46.); State v. [read post]
18 Dec 2014, 7:08 am by John Elwood
United States, 14-282, is yet another gift from the St. [read post]
18 Mar 2020, 10:10 am by Eugene Volokh
First Amendment rights are indivisible: If public officials and courts have discretion to suppress speech they don't like, then none of us truly enjoys the freedom of speech. [read post]
1 Jun 2009, 7:05 am
: Federal Administrative Court rulings in CALVI and TRELLEBORG cases (International Law Office) Motion marks: Swiss IPO allows Swisscom to file MPG-file of motion mark in motion (Class 46)   United Kingdom Class dispute over similarity of goods too complex for summary judgment: Daimler AG v Sany Group Co Ltd (Class 46) The war on counterfeits: how much would you spend? [read post]
3 Mar 2010, 2:30 pm
Ct., Suffolk Co., decided 12/23/2009) Elrac, Inc. [read post]
29 Aug 2018, 6:06 pm by Francis Pileggi
Allen was prescient when he stated in the famous 1988 Delaware Chancery Court case of Blasius Industries, Inc. v. [read post]
21 Aug 2015, 6:22 am by Joy Waltemath
United States, which requires the settlement to constitute “a fair and reasonable resolution of a bona fide dispute over FLSA provisions. [read post]
11 May 2009, 12:42 pm
The United States Supreme Court recently announced that it will hear an appeal in Jones v. [read post]
14 Aug 2014, 5:00 am
SUPREME COURT OF THE STATE OF NEW YORK COUNTY OF NEW YORK THE PEOPLE OF THE STATE OF NEW YORK By ERIC T. [read post]
27 Feb 2010, 4:59 pm
Chamberlain Group, Inc. v. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]